Therapure was built on the significant manufacturing and scientific experience of a successful Canadian biotech company. Therapure was launched in the third quarter of 2008 as a Contract Development and Manufacturing Organization (CDMO) and since then has completed a series of facility upgrades and capability enhancements. Therapure is privately held by Catalyst Fund Limited Partnership II, a Canadian based private equity fund, and management.